See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420030_2015_Targeted_Medical_Pharma_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420030, Targeted Medical Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 533,959 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,859,152 |
| 2 | PropertyPlantAndEquipmentNet | 107,185 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 12,349,580 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 122,290 |
| 7 | CostOfGoodsAndServicesSold | 2,063,756 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,684,002 |
| 9 | ResearchAndDevelopmentExpense | 178,245 |
| 10 | remainder_Expenses | 2,474,108 |
| 11 | remainder_Revenues | 7,620,182 |
| 12 | remainder_NetIncome | -705,791 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,500,296 |
| 1 | Liabilities | 12,471,870 |
| 2 | Expenses | 12,400,111 |
| 3 | Revenues | 7,620,182 |
| 4 | StockholdersEquity | -9,971,574 |
| 5 | NetIncome | -5,485,720 |
| 6 | ComprehensiveNetIncome | -5,485,720 |
| 7 | BaseVar | 17,849,125 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.64 |
| 9 | EconomicCapitalRatio | 0.490 |
Edgar->Model Mapping
Feature Distribution
Change over Time
